AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05574491 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Super Skills for Life: traditional version
Description: Structured and manualized intervention with a manual for the therapist and a workbook for the children.~The intervention will be administered by trained clinical psychologists in SSL. Sessions will be held once a week for eight weeks, with each session lasting approximately forty five minutes.~The program includes emotional education, social skills training, cognitive restructuring, relaxation techniques, self-observation, problem solving and behavioural activation. These contents are learned through playful exercises, activities, readings, and role-playing.~Both modalities of intervention will be in-person.~Spanish version of Super Skills for Life group program: Orgilés, M., Espada, J.P., Ollendick, T.H. \& Essau, C. (2022). Programa Super Skills. Manual del aplicador. Elche, ES: Universidad Miguel Hernández.
Study NCT05574491 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Super Skills for Life: computerized version
Description: Structured and manualized intervention with a manual for the therapist and multimedia material for the children.
Study NCT06133322 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Behavioral: Evidence-based interventions recommended by the 2017 ACC/AHA hypertension clinical guideline
Description: The recommended evidence-based interventions include therapeutic lifestyle change and medical treatment of hypertension
Study NCT05599308 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: OMRON blood pressure monitor with AFib screening feature
Description: Blood pressure measurement by an oscillometric blood pressure monitor
Study NCT05599308 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Microlife WatchBP Home A
Description: Blood pressure measurement by an oscillometric blood pressure monitor
Study NCT04752267 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Computed Tomography
Description: Undergo PET/CT
Study NCT04752267 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 18F-FMAU
Description: Given IV
Study NCT04752267 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Multiparametric Magnetic Resonance Imaging
Description: Undergo mpMRI
Study NCT04752267 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Positron Emission Tomography
Description: Undergo PET/CT
Study NCT05697783 — intervention group
Intervention type: DRUG
Intervention: Administration of methadone instead of fentanyl patch
Description: comparison of delirium rates in methadone vs fentanyl patch treated patients
Study NCT05308992 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: HydroGlyde Condom
Description: The latex HydroGlyde condom has a hydrophilic coating which maintains its lubricity when in contact with water. Improved lubrication during intercourse may lead to improved user satisfaction and increased condom use which would help prevent the spread of Sexually Transmitted Infections and unwanted pregnancies.
Study NCT05327179 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Action Observation Treatment
Description: Action Observation Treatment program will be applied to the group 1 for 3 weeks, 5 days a week, 30 minutes a day. In the videos prepared, activities including daily life activities for the wrist, elbow and shoulder (emptying water from the glass, throwing sugar into the glass, painting, using clothespins, spoons, etc.) will be included.
Study NCT05327179 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Virtual Rehabilitation
Description: Virtual Rehabilitation program will be applied to the group 2 for 3 weeks, 5 days a week, 30 minutes a day. Among the games, games that will improve daily life activities for the wrist, elbow and shoulder (steering wheel, popping balloons, touching the aquarium, etc.) will be selected.
Study NCT05478941 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Progressive Muscular Relaxation via Zoom, and Exposure to a Virtual Reality scenarios deployed by an Head mounted tool (Oculus Quest 2).
Description: * Four individual PMRT sessions via Zoom.~* In vivo PMRT relaxing session and Virtual Reality exposure (T1; day 7).~* Follow-up phase (T2; day 14), after two weeks. Recovering the virtual reality scenario based on an in-imagination session, and the PMRT session.
Study NCT05478941 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Progressive Muscular Relaxation via Audio-track, and Exposure to a Virtual Reality scenarios deployed by an Head mounted tool (Oculus Quest 2).
Description: * Four individual PMRT sessions via Audio-track.~* In vivo PMRT relaxing session and Virtual Reality exposure (T1; day 7).~* Follow-up phase (T2; day 14), after two weeks. Recovering the virtual reality scenario based on an in-imagination session, and the PMRT session.
Study NCT05478941 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Progressive Muscular Relaxation via Zoom, and Exposure to a Guided Imagery Exposure.
Description: * Four individual PMRT sessions via Zoom.~* In vivo PMRT relaxing session and Guided Imagery conducted by the Psychotherapist (T1; day 7).~* Follow-up phase (T2; day 14), after two weeks. Recovering the in-imagination relaxing scenario and PMRT session.
Study NCT06330740 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Clinical Decision Support
Description: Upon ordering antibiotics the provider will be prompted to utilize an indication-based order set which guides the clinician to the appropriate empiric antibiotic choice.
Study NCT05228665 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Heart Rate Variability Biofeedback (HRV-B)
Description: Breathing technique twice every day (10 min each) to increase HRV
Study NCT05677893 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: MBS-COV
Description: MBS-COV is a potent siRNA treatment for mild to moderate COVID-19.
Study NCT05677893 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Normal saline
Study NCT05714826 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Preop Intervention and Monitored Recovery
Description: Perioperative Optimization of Senior Health (POSH) Program; patient monitoring by device orientation, initial intake, education; ERAS protocol, inpatient geriatric co-management; and remote monitoring with Acticare device; post-op continuity of care
Study NCT05714826 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Usual Care
Description: ERAS, Usual referral and recovery care, and Standard follow-up protocol
Study NCT06543667 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Limbal Stem Cell Derived Exosomes Eye Drop
Description: Patients will receive artificial tears for 2 weeks to get the normalized baseline, followed by LSC-Exo eye drops 0.15 ml/single eye/one time, four times a day for 3 months. The follow-up visit will be 12 weeks since the administration of LSC-Exo eye drops.
Study NCT05128461 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Exercise
Description: M-CIMT-based telerehabilitation will be implemented.
Study NCT05128461 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Home program
Description: Lower and upper extremity exercises and gait training exercises selected according to the Bobath approach will be given as a home program consisting of 10 same exercises.
Study NCT05128461 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Home program
Description: Lower and upper extremity exercises and gait training exercises selected according to the Bobath approach will be given as a home program consisting of 10 same exercises.
Study NCT04763395 — intervention group
Intervention type: OTHER
Intervention: No intervention
Description: No intervention
Study NCT05892614 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: efzofitimod 450 mg
Description: IV infusion over approximately 60 minutes every 4 weeks
Study NCT05892614 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: efzofitimod 270 mg
Description: IV infusion over approximately 60 minutes every 4 weeks
Study NCT05892614 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: IV infusion over approximately 60 minutes every 4 weeks
Study NCT04300985 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Dexmedetomidine
Description: Patients will start receiving dexmedetomidine 15 minutes before general anesthetic induction.
Study NCT04300985 — intervention group
Intervention type: DRUG
Group type: SHAM_COMPARATOR
Intervention: Sham treatment
Description: Patients will start receiving saline solution infusion 15 minutes before general anesthetic induction.
Study NCT04300985 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Magnesium Sulfate
Description: Patient will start receiving magnesium infusion (20 mg/kg/h) 15 minutes before general anesthetic induction.
Study NCT05987358 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TQB3454 tablets
Description: TQB3454 is a selective IDH1 mutant enzyme inhibitor.
Study NCT05987358 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: TQB3454 tablets matching placebo
Description: Placebo tablets without active substance.
Study NCT06234033 — intervention group
Intervention type: BEHAVIORAL
Intervention: Discrimination Acuity test
Description: Estimating the just-noticeable difference of auditory loudness and vibrotactile displacement to fit a psychometric function for each modality with parameters: threshold, slope, sensitivity, and response criterion.
Study NCT06234033 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Transiently Evoked Otoacoustic Emission
Description: Examination of integrity of outer hair cells in the inner ear; with and without contralateral suppression.
Study NCT06234033 — intervention group
Intervention type: OTHER
Intervention: Questionnaires
Description: Caregiver questionnaires send to parents online to acquire demographic information Autism Quotient (AQ), Child Behavior Checklist (CBCL6-16), Sensory Profile 2 (SP-2).
Study NCT06234033 — intervention group
Intervention type: BEHAVIORAL
Intervention: Wechsler Intelligence Scale for Children, Fifth Edition (WISC-V)
Description: Estimates intelligence quotient
Study NCT06234033 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Clinical tests of ASD
Description: Autism Diagnostic Observation Schedule, 2nd edition (ADOS-2)
Study NCT06234033 — intervention group
Intervention type: OTHER
Intervention: Electroencephalography (EEG) with auditory or vibrotactile stimuli
Description: Two paradigms will be used: an auditory frequency tagging paradigm with interspersed pitch oddballs and a classical sensory gating paradigm with either vibrotactile stimuli or auditory clicks.
Study NCT06234033 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Clinical tests of ADHD
Description: ADHD-Rating Scale (ADHD-RS)
Study NCT06528366 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Chlorella pyrenoidosa
Description: Functional food, organically pressed into tablets (Registration with Anvisa/MS/Brazil: 6.7273.000)
Study NCT06528366 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: High Definition Transcranial Direct Current Stimulation
Description: Neuromodulation Technics, non invasive, target and safety
Study NCT06528366 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: High Definition Transcranial Direct Current Stimulation
Description: Neuromodulation Technics, non invasive, target and safety
Study NCT06391554 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: PRT
Description: An initial 12-week exercise intervention, consisting of 1-hour group sessions of progressive resistance training supervised by a physiotherapist 2 times per week. The sessions consist of a 10-minute submaximal warm up on an exercise bike followed by 50 minutes of PRT with exercises targeting the muscles of the hip and knee joints; leg press, hip extension, hip abduction, hip flexion and knee extension. The progression will be in line with guidelines provided by the American College of Sports Medicine. The intensity will follow repetition maximum (RM) targets, from 12 RM for the first week towards 8 RM for the last weeks. After the 12 weeks, participants will receive 8 booster sessions and are given a membership to a fitness center where they will be encouraged to continue the exercise program on their own.
Study NCT06391554 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: EDU
Description: Three EDU sessions provided by a trained physiotherapist involving important disease-specific information. The sessions will address knowledge of OA, treatment options with a specific focus on physical activity recommendations, advice on self-management and more. All three sessions will emphasize on engaging the participants actively and sharing experiences with each other.
Study NCT06391554 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: EDU
Description: Three EDU sessions provided by a trained physiotherapist involving important disease-specific information. The sessions will address knowledge of OA, treatment options with a specific focus on physical activity recommendations, advice on self-management and more. All three sessions will emphasize on engaging the participants actively and sharing experiences with each other.
Study NCT05416138 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Transcranial magnetic stimulation (TMS)
Description: TMS will be performed at either peaks or troughs of ongoing prefrontal theta oscillations (3-7 Hz) concurrently with the cognitive test at the beginning of every test trial. Theta oscillations will be monitored in real-time at the left dorsolateral prefrontal cortex using electroencephalography (EEG).
Study NCT05416138 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Transcranial magnetic stimulation (TMS)
Description: TMS will be performed at either peaks or troughs of ongoing prefrontal theta oscillations (3-7 Hz) concurrently with the cognitive test at the beginning of every test trial. Theta oscillations will be monitored in real-time at the left dorsolateral prefrontal cortex using electroencephalography (EEG).
Study NCT05963672 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: EEG-guided sleep protection
Description: The tablet will display a specific picture prioritize sleep or prioritize care depending on the patient status determined by the algorithm. When the picture favor/prioritize sleep is displayed, all caregivers and visiting family are asked to follow the sleep protection rules: refrain to enter the room for not urgent reasons, switch off television, reduced light in the room/corridor, reduce noise in front of the door, close curtain (if any), and delay non urgent care...etc; if caregivers have to enter the room, headlight and/or additional light will be favored. All these rules will be established collegially by nurses and doctors. Obviously, urgent care and reactions to alarms are maintained.~When the picture favor/prioritize care is displayed, all caregivers and visiting family are invited to perform non urgent care, cleaning, restocking perfusion needles, comfort care, visiting.
Study NCT05963672 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Control condition
Description: the recording device will be placed on the patient to record sleep but the tablet will be masked and placed face down on the bench in the room, invisible from the door.
Study NCT04688359 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Guided Self Determination
Description: Nurse lead intervention in primary care
Study NCT02528708 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: fibrinogen concentrate
Description: The dose of fibrinogen concentrate needed to achieve this target will be calculated using a formula that accounts for the baseline FIBTEM® - A10 value and the patient's body weight assessed at hospital admission . In general, a 70-kg patient requires a fibrinogen dose of approximately 0.5 g to increase the MCF by approximately 1 mm.
Study NCT02528708 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: 0.9% saline solution
Study NCT05627271 — intervention group
Intervention type: OTHER
Intervention: ocrelizumab
Description: Non-interventional, cross-sectional, qualitative study. There is no treatment allocation. Patients prescribed with Disease-modifying therapy in the commercial setting are eligible to enroll into this study.
Study NCT05627271 — intervention group
Intervention type: OTHER
Intervention: natalizumab
Description: Non-interventional, cross-sectional, qualitative study. There is no treatment allocation. Patients prescribed with Disease-modifying therapy in the commercial setting are eligible to enroll into this study.
Study NCT05627271 — intervention group
Intervention type: OTHER
Intervention: ofatumumab
Description: Non-interventional, cross-sectional, qualitative study. There is no treatment allocation. Patients prescribed with Disease-modifying therapy in the commercial setting are eligible to enroll into this study.
Study NCT05574296 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Hydrogen
Description: Hydrogen gas (2%) in air or oxygen administered for 72 hours via ventilator and ECMO membrane. Oxygen concentration titrated per clinical team.
Study NCT05574296 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Usual care
Description: Usual care post-ECPR event, including targeted temperature management.
Study NCT05574296 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Usual care
Description: Usual care post-ECPR event, including targeted temperature management.
Study NCT05069103 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Intervention
Description: Similar to the original TWIST trial , patients will receive access to the online tool hosted on the ISLA platform until postoperative day 30 which is composed of two parts:~1. A series of simple questions related to the detection of surgical wound infection (e.g. redness, swelling, fluid leakage, etc). These questions would be expected to be routinely asked during in-person assessment, and these questions have been previously developed and tested within the TWIST trial (the only change being the addition of questions specifically relating to the change in these symptoms).~2. At least one image of their surgical wound(s).
Study NCT05257278 — intervention group
Intervention type: DEVICE
Intervention: MonoPlus®
Description: MonoPlus® is indicated for use in general soft tissue approximation, specially in cases where extended wound support of more than 4 weeks is desirable
Study NCT06356402 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Oral Health Educational Module for Mothers (OHEM) lecture
Description: OHEM via lecture will be delivered to the mothers by an oral health professional who will be instructed to teach their children.
Study NCT06356402 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Oral Health Educational Module for Mothers (OHEM) exhibition
Description: OHEM via exhibition will be delivered to the mothers who will be instructed to teach their children.
Study NCT06356402 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Oral Health Educational Module for Mothers (OHEM) demonstration
Description: OHEM via demonstration will be delivered to the mothers by an oral health professional who will be instructed to teach their children.
Study NCT05318001 — intervention group
Intervention type: OTHER
Intervention: Evaluation of biomechanics and viscoelastic properties of plantar fascia
Description: The biomechanical (Tone-Hz, Stiffness-N/m and decrement) and viscoelastic (creep and relaxation time-ms) properties of the plantar fascia will be measured in the side lying position.~Measurements will be made with the ankle in neutral position.
Study NCT05318001 — intervention group
Intervention type: OTHER
Intervention: Evaluation of Foot Morphological Characteristics
Description: Foot length and width will be measured.
Study NCT05318001 — intervention group
Intervention type: OTHER
Intervention: Evaluation of navıcular mobility
Description: The amount of navicular drop of both feet will be measured.
Study NCT05318001 — intervention group
Intervention type: OTHER
Intervention: Evaluation of Foot Posture
Description: Foot posture will be evaluated according to Foot Posture Index.
Study NCT05103826 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SHR6390、Famitinib
Description: SHR6390, oral;Famitinib, oral.
Study NCT05175092 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Living Donor Liver Transplantation
Description: The LDLT will be performed by the UW Division of Transplantation in accordance with the standard of care for this operation.
Study NCT04694235 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Egg intervention
Description: Eggs are boiled until the white and yolk are firm (ca. 8 minutes) to maintain quality and safety and ensure the eggs are safe for consumption.
Study NCT05036304 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Aerobic Exercise Indoors
Description: Each session will consist of 10 min of warm-up, 40 min of aerobic exercise, and 10 min of cool-down. Aerobic exercise will be progressive and of moderate intensity. During training, each participant will wear a heart rate monitor and will be asked to work initially at approximately 45% of his/her target heart rate (i.e., heart rate reserve (HRR)) and gradually progress to reach the target of 70% of HRR over the 12-week study period. Participants will also subjectively monitor workout intensity using the 20-point Borg's Rating of Perceived Exertion. Participants will walk or jog on treadmills or cycle on stationary bikes in the Exercise Prescription Suite of the Centre for Hip Health and Mobility.